SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 3, Issue 4, 2014, Pages

A critical role for natural killer cells in dendritic cellbased anticancer immunotherapy

(1) McLellan, Alexander D a

a UNIVERSITY OF OTAGO (New Zealand)

Author keywords

Cancer; Dendritic cell; Immunotherapy; Melanoma; Natural killer cell

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DENDRITIC CELL VACCINE;

ADOPTIVE TRANSFER; ARTICLE; CANCER IMMUNIZATION; CANCER PREVENTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DRUG EFFICACY; DRUG RESPONSE; GENOMIC INSTABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MELANOMA; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 84902603044 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.4161/onci.28582 Document Type: Article

Times cited : (3)

References (10)

1
- 84866106396
- Biological heterogeneity of cancer: implication to therapy
- PMID:22854675
- Fidler IJ. Biological heterogeneity of cancer: implication to therapy. Hum Vaccin Immunother 2012; 8:1141-2; PMID:22854675; http://dx.doi.org/10.4161/hv.19643
- (2012) Hum Vaccin Immunother , vol.8 , pp. 1141-1142
- Fidler, I.J.¹

2
- 84893524264
- Dendritic cells and cancer immunotherapy
- PMID:24513968
- Radford KJ, Tullett KM, Lahoud MH. Dendritic cells and cancer immunotherapy. Curr Opin Immunol 2014; 27C:26-32; PMID:24513968; http://dx.doi.org/10.1016/j.coi.2014.01.005
- (2014) Curr Opin Immunol , vol.27 C , pp. 26-32
- Radford, K.J.¹ Tullett, K.M.² Lahoud, M.H.³

3
- 0035892376
- Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination:cessation of CTL responses is associated with disease progression
- PMID:11745484
- Andersen MH, Keikavoussi P, Bröcker EB, Schuler-Thurner B, Jonassen M, Søndergaard I, Straten PT, Becker JC, Kämpgen E. Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination:cessation of CTL responses is associated with disease progression. Int J Cancer 2001; 94:820-4; PMID:11745484; http://dx.doi.org/10.1002/ijc.1536
- (2001) Int J Cancer , vol.94 , pp. 820-824
- Andersen, M.H.¹ Keikavoussi, P.² Bröcker, E.B.³ Schuler-Thurner, B.⁴ Jonassen, M.⁵ Søndergaard, I.⁶ Straten, P.T.⁷ Becker, J.C.⁸ Kämpgen, E.⁹

4
- 84879599112
- At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- PMID:23667165
- Callahan MK, Wolchok JD. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol 2013; 94:41-53; PMID:23667165; http://dx.doi.org/10.1189/jlb.1212631
- (2013) J Leukoc Biol , vol.94 , pp. 41-53
- Callahan, M.K.¹ Wolchok, J.D.²

5
- 84892156997
- Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells
- PMID:24391651
- Mentlik James A, Cohen AD, Campbell KS. Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells. Front Immunol 2013; 4:481; PMID:24391651; http://dx.doi.org/10.3389/fimmu.2013.00481
- (2013) Front Immunol , vol.4 , pp. 481
- Mentlik James, A.¹ Cohen, A.D.² Campbell, K.S.³

6
- 84881431200
- Rapid interferon- gamma release from natural killer cells induced by a streptococcal commensal
- PMID:23659669
- Bouwer AL, Saunderson SC, Dunn AC, Lester KL, Crowley LR, Jack RW, McLellan AD. Rapid interferon- gamma release from natural killer cells induced by a streptococcal commensal. J Interferon Cytokine Res 2013; 33:459-66; PMID:23659669; http://dx.doi.org/10.1089/jir.2012.0116
- (2013) J Interferon Cytokine Res , vol.33 , pp. 459-466
- Bouwer, A.L.¹ Saunderson, S.C.² Dunn, A.C.³ Lester, K.L.⁴ Crowley, L.R.⁵ Jack, R.W.⁶ McLellan, A.D.⁷

7
- 84896526831
- NK cells are required for dendritic cellbased immunotherapy at the time of tumor challenge
- PMID:24477907
- Bouwer AL, Saunderson SC, Caldwell FJ, Damani TT, Pelham SJ, Dunn AC, Jack RW, Stoitzner P, McLellan AD. NK cells are required for dendritic cellbased immunotherapy at the time of tumor challenge. J Immunol 2014; 192:2514-21; PMID:24477907; http://dx.doi.org/10.4049/jimmunol.1202797
- (2014) J Immunol , vol.192 , pp. 2514-2521
- Bouwer, A.L.¹ Saunderson, S.C.² Caldwell, F.J.³ Damani, T.T.⁴ Pelham, S.J.⁵ Dunn, A.C.⁶ Jack, R.W.⁷ Stoitzner, P.⁸ McLellan, A.D.⁹

8
- 84881467787
- Increased numbers of monocytederived dendritic cells during successful tumor immunotherapy with immune-activating agents
- PMID:23858033
- Kuhn S, Hyde EJ, Yang J, Rich FJ, Harper JL, Kirman JR, Ronchese F. Increased numbers of monocytederived dendritic cells during successful tumor immunotherapy with immune-activating agents. J Immunol 2013; 191:1984-92; PMID:23858033; http://dx.doi.org/10.4049/jimmunol.1301135
- (2013) J Immunol , vol.191 , pp. 1984-1992
- Kuhn, S.¹ Hyde, E.J.² Yang, J.³ Rich, F.J.⁴ Harper, J.L.⁵ Kirman, J.R.⁶ Ronchese, F.⁷

9
- 84897476768
- Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
- PMID:24598590
- Zamarin D, Holmgaard RB, Subudhi SK, Park JS, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP. Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy. Sci Transl Med 2014; 6:226ra32; PMID:24598590; http://dx.doi.org/10.1126/scitranslmed.3008095
- (2014) Sci Transl Med , vol.6 , pp. 226-232
- Zamarin, D.¹ Holmgaard, R.B.² Subudhi, S.K.³ Park, J.S.⁴ Mansour, M.⁵ Palese, P.⁶ Merghoub, T.⁷ Wolchok, J.D.⁸ Allison, J.P.⁹

10
- 84894582150
- Combining low-dose or metronomic chemotherapy with anticancer vaccines:A therapeutic opportunity for lymphomas
- PMID:24498564
- Sheng Sow H, Mattarollo SR. Combining low-dose or metronomic chemotherapy with anticancer vaccines:A therapeutic opportunity for lymphomas. Oncoimmunology 2013; 2:e27058; PMID:24498564; http://dx.doi.org/10.4161/onci.27058
- (2013) Oncoimmunology , vol.2
- Sheng Sow, H.¹ Mattarollo, S.R.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.